small molecule

ESTRADIOL

ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameESTRADIOL
Active ingredientESTRADIOL
Strength0.1% (1GM/PACKET)
Dosage formGEL
RouteTRANSDERMAL
ModalitySmall molecule
FDA approvalJuly 2024
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.